VCs Applaud JOBS Act, But Will It Open Doors For Life Science Start-Ups?
This article was originally published in The Pink Sheet Daily
Executive Summary
“Emerging growth” start-ups will enjoy less regulation during their first five years as public companies, easing the burden on new listings while giving IPO prospects more leverage against buyers.